| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | US5149792 Recombinant protein comprising amino acids 1-119 of PDGF B109 precursor; mitogenesis at site of injured connective tissue; expressed from Escherichia host cells |
| 09/22/1992 | US5149788 Adsorption, desorption; single step from bacterial extract or conditioned medium |
| 09/22/1992 | US5149787 Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
| 09/22/1992 | US5149786 Free of adrenal and brain derived proteins, useful for treating perkinson's disease and schizophrenia |
| 09/22/1992 | US5149785 Proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses |
| 09/22/1992 | US5149783 Polypeptide capable of being cleaved by protease of rhinovirus for use as a test system for inhbitors of viral proteases and an assay for identifying viral inhibitors |
| 09/22/1992 | US5149781 Steroid/thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma |
| 09/22/1992 | US5149780 60 to 90 amino acid residues in length, ability to prevent receptor mediated cell adhesion such as aggregation of platelets and fibroblasts to a matrix |
| 09/22/1992 | US5149779 Anticarcinogenic and -tumor agents; osteoporosis; glandular disorders |
| 09/22/1992 | US5149777 Human insulin analogs and preparations containing them |
| 09/22/1992 | US5149716 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them |
| 09/22/1992 | US5149660 Diagnostic reagents relating to herpes simplex virus |
| 09/22/1992 | US5149657 Escherichia coli expression vector encoding bioadhesive precursor protein analogs comprising three to twenty repeats of the decapeptide (Ala-Lys-Pro-Ser-Tyr-Pro-Pro-Thr-Tyr-Lys) |
| 09/22/1992 | US5149650 Recombinant DNA, coding sequences, host cells |
| 09/22/1992 | US5149647 Micrifltration; selective adsorption on strong cation exchange resin; successive and selective elution with saline solutions |
| 09/22/1992 | US5149637 Recombinant Factor VIIIC fragments |
| 09/22/1992 | US5149623 Dot enzyme immunoassay; colorimetric analysis |
| 09/22/1992 | US5149544 Method of inhibiting progenitor cell proliferation |
| 09/22/1992 | US5149532 Transforming lactobacillus by recombinant DNA technology to express herpes virus glycoprotein D, growing lactobacillus in culture media, harvesting by separation |
| 09/22/1992 | CA1307753C Dna sequences, recombinant dna molecules and processes for producing mullerian inhibiting substance-like polypeptides |
| 09/22/1992 | CA1307752C Immunoaffinity purification system |
| 09/20/1992 | WO1992016546A1 Response element compositions and assays employing same |
| 09/20/1992 | CA2100584A1 Response element compositions and assays employing same |
| 09/20/1992 | CA2063316A1 Dna and amino acid sequence of penicillin binding protein 2a from staphylococcus aureus strain 27r and derivatives for use in purification thereof and assay for compounds effective against methicillin resistant organisms |
| 09/20/1992 | CA2063306A1 Process for the chemical modification of proteins |
| 09/19/1992 | WO1992016658A1 Response element compositions and assays employing same |
| 09/19/1992 | WO1992016555A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2101918A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/19/1992 | CA2100582A1 Response element compositions and assays employing same |
| 09/18/1992 | CA2063239A1 Stimulating factor of the neu receptor |
| 09/17/1992 | WO1992015887A1 Biosynthetic cerebrospinal fluid control and method of use |
| 09/17/1992 | WO1992015884A1 Novel protein, method and products for detection of oligodendrocytes |
| 09/17/1992 | WO1992015693A1 Chimeric tar enzyme construction for hiv therapy |
| 09/17/1992 | WO1992015691A1 Biocidal proteins |
| 09/17/1992 | WO1992015690A1 Nematode control with proteinase inhibitors |
| 09/17/1992 | WO1992015689A1 Expression of recombinant proteins in attenuated bacteria |
| 09/17/1992 | WO1992015688A1 Production of recombinant proteins |
| 09/17/1992 | WO1992015687A1 Fused genes and their use for determining the presence of metals or of xenobiotic compounds |
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015684A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN |
| 09/17/1992 | WO1992015680A1 Methods and compositions for the selective inhibition of gene expression |
| 09/17/1992 | WO1992015678A1 Pcr generated dicistronic dna molecules for producing antibodies |
| 09/17/1992 | WO1992015677A1 Process for the development of binding mini-proteins |
| 09/17/1992 | WO1992015673A1 Cloning and expression of renilla luciferase |
| 09/17/1992 | WO1992015672A1 Genetically engineered vaccine strain |
| 09/17/1992 | WO1992015671A1 Soluble cd28 proteins and methods of treatment therewith |
| 09/17/1992 | WO1992015615A1 Serum calcium depressing factor |
| 09/17/1992 | WO1992015614A1 Method for the stabilization of methionine-containing polypeptides |
| 09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
| 09/17/1992 | WO1992015612A1 Curculin b, dna coding for the same, and production of both of them |
| 09/17/1992 | WO1992015611A1 Novel insulin derivatives |
| 09/17/1992 | WO1992015609A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | WO1992015607A2 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 09/17/1992 | WO1992015606A1 New inhibitors of endothelial cell proliferation |
| 09/17/1992 | WO1992015605A2 Inhibitors of human neutrophil elastase and human cathepsin g |
| 09/17/1992 | WO1992015603A1 Prad1 cyclin and its cdna |
| 09/17/1992 | WO1992015602A1 Cancer diagnosis and therapy |
| 09/17/1992 | WO1992015600A1 Cancer diagnosis and therapy |
| 09/17/1992 | WO1992015330A1 Method for anti-lhrh immunoneutralization for ungelded male domestic animals and peptide therefor |
| 09/17/1992 | WO1992015328A1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 09/17/1992 | WO1992015327A1 Recombinant double chain immunotoxins |
| 09/17/1992 | WO1992015324A1 Preparation of factor ix |
| 09/17/1992 | WO1992015323A1 Protein-induced morphogenesis |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992015320A1 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, dna encoding same and uses thereof |
| 09/17/1992 | WO1992015318A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 09/17/1992 | WO1992015317A1 Synthetic preparation of amylin and amylin analogues |
| 09/17/1992 | WO1992015316A1 Modified proteins and their use for controlling viral infections |
| 09/17/1992 | WO1992015279A1 Cosmetic composition containing at least one purified peptide as active principle obtainable by hydrolysis of casein with opiod activity |
| 09/17/1992 | WO1992015195A1 Insecticidally effective peptides |
| 09/17/1992 | WO1992013553A3 Method and agents for promoting wound healing |
| 09/17/1992 | WO1992013072A3 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
| 09/17/1992 | CA2108144A1 Methods and compositions for the selective inhibition of gene expression |
| 09/17/1992 | CA2107234A1 Nematode control with proteinase inhibitors |
| 09/17/1992 | CA2106092A1 Biocidal proteins |
| 09/17/1992 | CA2105863A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | CA2104964A1 Cancer diagnosis and therapy with tumor suppressor genes |
| 09/17/1992 | CA2104958A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 09/17/1992 | CA2103901A1 Insecticidally effective peptides isolatable from diguetia spider venom |
| 09/17/1992 | CA2081481A1 Biosynthetic cerebrospinal fluid control and method of use |
| 09/16/1992 | WO1992016845A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | WO1992016230A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 09/16/1992 | WO1992016221A1 Pegylation of polypeptides |
| 09/16/1992 | WO1992016219A1 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
| 09/16/1992 | EP0504043A1 Cosmetic composition containing phospholipid transfer proteins |
| 09/16/1992 | EP0503991A1 Process for preparing a highly purified standardized concentrate of human von Willebrand factor on industrial scale, appropriate for therapeutic use |
| 09/16/1992 | EP0503950A2 Method of purifying recombinant hepatitis B virus surface proteins from recombinant cells |
| 09/16/1992 | EP0503939A1 Antimicrobial peptide and antimicrobial agent |
| 09/16/1992 | EP0503827A1 Amylin and calcitonin gene-related peptide use and antagonists thereof |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503646A1 Monoclonal antibodies recognizing lymphocyte function associated antigen-3 |
| 09/16/1992 | EP0503505A1 Purified mite allergen |
| 09/16/1992 | EP0503301A2 Peptide derivatives and application thereof |
| 09/16/1992 | EP0503297A1 GLIA activating factor and its production |
| 09/16/1992 | EP0503293A1 Specific chicken egg antibody and method for its production |
| 09/16/1992 | EP0503252A2 Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines |
| 09/16/1992 | EP0503055A1 Inhibitor of lymphocyte response and immune-related disease |